Haleon plc

Haleon plc EBIT Margin

The EBIT Margin (Operating Margin) of Haleon plc (HLN) as of Oct 29, 2026 is 22.44 %. In the previous year, EBIT Margin (Operating Margin) was 19.64 % — a change of 14.26% (higher).

EBIT Margin

22.44 %

YoY

14.26%

Last updated:

EBIT Margin (Operating Margin) of Haleon plc is 2025 22.44 % . EBIT Margin (Operating Margin) of Haleon plc was 2024 19.64 % . It decreases by 14.26% higher compared to the previous year.

For Haleon plc, the operating (EBIT) margin of 22.4% is up versus 17.2% a few years ago.

The Haleon plc EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
10.58 USD
Jan 1, 2020
16.15 USD
Jan 1, 2021
17.16 USD
Jan 1, 2022
16.81 USD
Jan 1, 2023
17.66 USD
Jan 1, 2024
19.64 USD
Jan 1, 2025
22.44 USD
The Haleon plc EBIT Margin history
YEAREBIT MarginYoY
22.44 %+14.26%
19.64 %+11.20%
17.66 %+5.07%
16.81 %-2.06%
17.16 %+6.23%
16.15 %+52.72%
10.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haleon plc Stock analysis

What does Haleon plc do? Haleon plc generates revenue through the sale of consumer healthcare products under well-known brands such as Sensodyne, Polident, Parodontax, and Biotene for oral health, and Centrum, Emergen-C, and Caltrate for vitamins and supplements. The company also sells over-the-counter products including Theraflu and Flonase for respiratory issues, Voltaren, Panadol, and Advil for pain relief, and TUMS, ENO, and Fenistil for digestive health. These products are sold across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific regions. Haleon's portfolio targets consumers seeking solutions for oral care, respiratory ailments, pain management, and digestive wellness through established brand names. The company's revenue streams are derived from direct sales to retailers and distributors who stock these branded products in pharmacies, supermarkets, and online platforms. Haleon focuses on building strong brand recognition and loyalty among health-conscious consumers in multiple geographic markets. Its products are positioned as trusted solutions for everyday health concerns, appealing to a broad demographic across different income levels and age groups. Haleon's business model emphasizes leveraging its portfolio of acquired brands, including Sensodyne and Centrum, to maintain market leadership in key healthcare categories. By offering a diverse range of products under recognizable names, Haleon ensures consistent demand from consumers who rely on these brands for their health needs. The company's strategy centers on sustaining brand equity and expanding market presence through continuous innovation and targeted marketing efforts. Haleon plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haleon plc stock

EBIT Margin (Operating Margin) of Haleon plc is 22.44 % in 2025.

EBIT Margin (Operating Margin) of Haleon plc changed from 19.64 % to 22.44 %, representing a 14.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Haleon plc since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Haleon plc with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Haleon plc

All Key Metrics — Haleon plc